SHOULDER INNOVATIONS, INC. Interest Expense Nonoperating
SHOULDER INNOVATIONS, INC. (SI) reported Interest Expense Nonoperating of -$673.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. interest expense nonoperating for the quarter ending 2026-06-30 was -$673.00K, a 411.57% decline year-over-year.
- SHOULDER INNOVATIONS, INC. interest expense nonoperating for the quarter ending 2026-03-31 was -$436.00K, a 218.80% decline year-over-year.
- SHOULDER INNOVATIONS, INC. interest expense nonoperating for the quarter ending 2025-12-31 was -$591.00K, a 251.15% decline year-over-year.
- SHOULDER INNOVATIONS, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $78.00K, a 75.32% decline year-over-year.
- SHOULDER INNOVATIONS, INC. interest expense nonoperating for fiscal 2025 was $70.00K, a 94.68% decline from fiscal 2024.
- SHOULDER INNOVATIONS, INC. interest expense nonoperating for fiscal 2024 was $1.32M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$673.00K 10-Q · filed 2026-08-06 | -$1.11M 10-Q · filed 2026-08-06 | -$1.70M derived: sum of 3 quarters · filed 2026-08-06 | -$1.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$436.00K 10-Q · filed 2026-05-13 | -$1.03M derived: sum of 2 quarters · filed 2026-05-13 | -$949.00K derived: sum of 3 quarters · filed 2026-05-13 | -$733.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$513.00K derived: sum of 2 quarters · filed 2026-03-10 | -$297.00K derived: sum of 3 quarters · filed 2026-08-06 | $70.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $78.00K 10-Q · filed 2025-11-12 | $294.00K derived: sum of 2 quarters · filed 2026-08-06 | $661.00K 10-Q · filed 2025-11-12 | $1.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $216.00K 10-Q · filed 2026-08-06 | $583.00K 10-Q · filed 2026-08-06 | $974.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $367.00K 10-Q · filed 2026-05-13 | $758.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.07M derived: sum of 3 quarters · filed 2026-05-13 | $1.37M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $707.00K derived: sum of 2 quarters · filed 2026-03-10 | $999.00K derived: sum of 3 quarters · filed 2026-03-10 | $1.32M 10-K · filed 2026-03-10 |
| 2024-09-30 | $316.00K 10-Q · filed 2025-11-12 | $608.00K derived: sum of 2 quarters · filed 2025-11-12 | $925.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $292.00K 10-Q · filed 2025-09-09 | $609.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |